Clinical trials
Phase 2 Neurodevelopmental Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| Connecta Therapeutics, S.L. | 1 |
| Holland Bloorview Kids Rehabilitation Hospital | 1 |
| Richard Frye | 1 |
| University of British Columbia | 1 |
| University of Calgary | 1 |
| University of North Carolina, Chapel Hill | 1 |
| Yaupon Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodevelopmental Disorders | 9 |
| Attention Deficit Disorder with Hyperactivity | 3 |
| Autism Spectrum Disorder | 3 |
| Autistic Disorder | 3 |
| Fragile X Syndrome | 2 |
| 22q11 Deletion Syndrome | 1 |
| Anxiety Disorders | 1 |
| Attention Deficit and Disruptive Behavior Disorders | 1 |
| Central Nervous System Diseases | 1 |
| Congenital Abnormalities | 1 |
Trials
Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.